TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,801,000 | +23.2% | 701,201 | +36.4% | 0.07% | +7.5% |
| Q1 2021 | $5,522,000 | -34.3% | 514,175 | -10.1% | 0.07% | -40.7% |
| Q4 2020 | $8,410,000 | +4.0% | 571,675 | +0.4% | 0.11% | -26.6% |
| Q3 2020 | $8,088,000 | +25.1% | 569,154 | -28.8% | 0.15% | +77.0% |
| Q2 2020 | $6,464,000 | +840.9% | 799,000 | +370.0% | 0.09% | +102.3% |
| Q1 2020 | $687,000 | +449.6% | 170,000 | +671.1% | 0.04% | +168.8% |
| Q4 2016 | $125,000 | -57.8% | 22,047 | +10.2% | 0.02% | -68.0% |
| Q3 2016 | $296,000 | +64.4% | 20,000 | 0.0% | 0.05% | +25.0% |
| Q2 2016 | $180,000 | +80.0% | 20,000 | +84.5% | 0.04% | -2.4% |
| Q1 2016 | $100,000 | – | 10,841 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |